文献速递临床试验与 GCP

低预后女性体外受精治疗中冻融胚胎移植与新鲜胚胎移植的比较:实用性多中心随机对照试验

Frozen versus fresh embryo transfer in women with low prognosis for in vitro fertilisation treatment: pragmatic, multicentre, randomised controlled trial.
PubMed 文献 · BMJ · 2025-01-29

该实用性多中心随机对照试验在中国九家学术生育中心纳入838例低预后女性,随机接受冻融胚胎移植或新鲜胚胎移植。意向性分析显示冻融胚胎移植组活产率低于新鲜胚胎移植组(32% vs 40%,相对比0.79,95%CI 0.65至0.94,P=0.009)。作者认为对于低预后女性,新鲜胚胎移植在活产率方面可能是更好的选择。

要点

  • 低预后女性冻融胚胎移植组活产率32%,低于新鲜胚胎移植组的40%。
  • 冻融胚胎移植组临床妊娠率39%,低于新鲜胚胎移植组的47%。
  • 冻融胚胎移植组一年内累积活产率44%,低于新鲜胚胎移植组的51%。

核心结论

  • 对于低预后女性,新鲜胚胎移植在活产率方面可能优于全胚冷冻策略。
  • 作者认为,在低预后女性中,防止新鲜胚胎移植的治疗策略(如连续周期累积胚胎或常规进行胚胎植入前非整倍体遗传学检测)需进一步研究。

研究设计与样本

  • 实用性、多中心、随机对照试验,在中国九家学术生育中心开展。
  • 共纳入838例低预后女性,低预后定义为获卵数≤9个或卵巢储备不良(窦卵泡计数<5或血清抗苗勒管激素水平<8.6 pmol/L)。
  • eligible participants were randomised (1:1) to undergo either frozen embryo transfer or fresh embryo transfer on the day of oocyte retrieval.

主要发现

  • 意向性分析中,冻融胚胎移植组活产率为32%(132/419),新鲜胚胎移植组为40%(168/419),相对比0.79(95%CI 0.65至0.94),P=0.009。
  • 冻融胚胎移植组临床妊娠率为39%(164/419),新鲜胚胎移植组为47%(197/419),相对比0.83(95%CI 0.71至0.97)。
  • 冻融胚胎移植组一年内累积活产率为44%(185/419),新鲜胚胎移植组为51%(215/419),相对比0.86(95%CI 0.75至0.99)。
  • 出生体重、产科并发症发生率或新生儿疾病风险方面未观察到差异。

临床怎么用

  • 作者认为,对于低预后女性,新鲜胚胎移植在活产率方面可能是更好的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that a freeze-all strategy would increase the chance of live birth compared with fresh embryo transfer in women with low prognosis for in vitro fertilisation (IVF) treatment. DESIGN: Pragmatic, multicentre, randomised controlled trial. SETTING: Nine academic fertility centres in China. PARTICIPANTS: 838 women with a low prognosis for IVF treatment defined by ≤9 oocytes retrieved or poor ovarian reserve (antral follicle count <5 or serum anti-Müllerian hormone level <8.6 pmol/L). INTERVENTIONS: Eligible participants were randomised (1:1) to undergo either frozen embryo transfer or fresh embryo transfer on the day of oocyte retrieval. Participants in the frozen embryo transfer group had all of their embryos cryopreserved and underwent frozen embryo transfer later. Participants in the fresh embryo transfer group underwent fresh embryo transfer after oocyte retrieval. MAIN OUTCOME MEASURES: The primary outcome was live birth, defined as the delivery of neonates with a heartbeat and respiration at ≥28 weeks' gestation. Secondary outcomes were clinical pregnancy, singleton or twin pregnancy, pregnancy loss, ectopic pregnancy, birth weight, maternal and neonatal complications, and cumulative live birth after embryo transfers within one year after randomisation. RESULTS: In an intention-to-treat analysis, the rate of live birth was lower in the frozen embryo transfer group than in the fresh embryo transfer group (32% (132 of 419) v 40% (168 of 419); relative ratio 0.79 (95% confidence interval 0.65 to 0.94); P=0.009). The frozen embryo group had a lower rate of clinical pregnancy than the fresh embryo group (39% (164 of 419) v 47% (197 of 419); 0.83 (0.71 to 0.97)). The cumulative live birth rate was lower in the frozen embryo transfer group compared with the fresh embryo transfer group (44% (185 of 419) v 51% (215 of 419), 0.86 (0.75 to 0.99)). No difference was observed in birth weight, incidence of obstetric complications, or risk of neonatal morbidities. CONCLUSIONS: Fresh embryo transfer may be a better choice for women with low prognosis in terms of live birth rate compared with a freeze-all strategy. The treatment strategies that prevent fresh embryo transfers, such as accumulating embryos with back-to-back cycles or performing routine preimplantation genetic testing for aneuploidy, warrant further studies in women with a low prognosis. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100050168.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Wei D, Sun Y, Zhao H, et al. Frozen versus fresh embryo transfer in women with low prognosis for in vitro fertilisation treatment: pragmatic, multicentre, randomised controlled trial. BMJ. 2025. PMID: 39880462. doi:10.1136/bmj-2024-081474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。